Transparency Market Research includes new market research report "D-dimer Testing Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast 2014 - 2022" to its huge collection of research reports.

Albany, NY -- (SBWire) -- 06/23/2015 --The medical industry today is geared toward diagnosing conditions in an accurate yet timely manner via the heightened use of in vitro diagnostic tools. Using these tools, it is possible for medical practitioners to screen, diagnose, stage, and manage diseases to prescribe the right drugs in the right doses. Similarly, the D-dimer test is now widely used to screen for and diagnose thrombosis so that medical practitioners can take a better decision about whether or not a patient suffers from conditions such as deep vein thrombosis (DVT), disseminated intravascular coagulation (DIC), or pulmonary embolism (PE). This has created a multibillion-dollar global D-dimer tests market.

Browse Full Global D-Dimer Testing Market Report With Complete TOC @
http://www.transparencymarketresearch.com/d-dimer-market.html

Cost- and Time-Saving Attributes of D-dimer Tests Encourage Higher Uptake

There are several benefit associated with D-dimer tests. For one, they help bypass imaging procedures that can otherwise be prevented. And in doing so, they also help reduce the duration of hospitalization, ultimately helping to bring down costs. By conducting D-dimer tests, it is also possible to avoid invasive procedures and the many infection risks associated with them. Thus, the D-dimer tests market is primarily driven by the many advantages of such tests. As patients and healthcare practitioners try to work a way around radiological intervention, D-dimer tests fill this need rather efficiently. With several compact D-dimer tests now available on the market, their convenience quotient (from the standpoint of medical practitioners) has moved several notches higher.

Laboratory Tests Most Common, but Point-of-Care Tests Becoming Sought-After in D-dimer Testing Market

The global D-dimer testing market can be broadly segmented on the basis of various testing methods, applications, as well as geographical region. The key testing methods comprise: Point-of-care and laboratory tests. While the latter has conventionally been the testing method of choice of in the D-dimer testing market, the former is now gaining momentum to potentially emerge as the leading segment in the market. Point-of-care D-dimer testing presents healthcare providers with several desirable options such as convenience, rapid turnaround time, and accurate results. They thus accelerate the entire screening, diagnosis or treatment method. The most commonly-seen diseases where D-dimer testing is used are: DIC, PE, and DVT.

Requesting for sample :
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2398

High Demand for Coagulation Testing Seen as Chief Growth Driver but Growth Challenges Still Prevail

The global D-dimer testing market has several factors that work in its favor. The most important among these are: A marked increase in patients undergoing coagulation testing, cutting-edge technological breakthroughs (such as sensitive hemostasis markers compatible with automated instruments), and the need to monitor patients undergoing anti-coagulation therapy.

On the flip side, it is still considered a challenge to accurately interpret the levels of D-dimer among the geriatric population. The key factor behind this is the spiraling rate of age-related thrombosis. In such conditions, the efficacy of D-dimer tests is reduced by several degrees in excluding PE or DVT. Also, the point-of-care D-dimer testing market is still struggling to gain widespread acceptance in both small clinics and larger hospitals because they are not perceived to offer the same degree of bioequivalence as lab services. This is especially seen to be the case in emergency departments.Overall, the global D-dimer testing market is expected to register a somewhat tepid CAGR of 2.6% between 2014 and 2022 to stand at US$ 1.9 billion by 2022.